Foamix Pharmaceuticals Ltd. Gross Margin
- Gross margin · 12 months: Value 100.00%; Formula and calculation Gross profit / revenue. Period ending 2019-12-31..
Gross margin
Overview →Financial period ending 2019-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 100.00% | Gross profit / revenue. Period ending 2019-12-31. $443.00K ÷ $443.00K × 100 ≈ 100.00% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 443.00K USD | Gross Profit |
| Revenue | 443.00K USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2019-12-31 | $443.00K | $443.00K | (m) | 100.00% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | $3.00M | $3.00M | (m) | 100.00% |
| 2018-12-31 | $3.60M | $3.60M | (m) | 100.00% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | $3.63M | $3.65M | (m) | 99.64% |
| 2017-12-31 | $3.66M | $3.67M | (m) | 99.65% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $5.68M | $5.71M | (m) | 99.51% |
| 2016-12-31 | $5.47M | $5.53M | (m) | 98.93% |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | $779.00K | $849.00K | (m) | 91.76% |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2014-12-31 | $4.89M | $5.41M | (m) | 90.27% |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $951.00K | $1.40M | (m) | 67.74% |
| 2012-12-31 | $595.00K | $1.09M | (m) | 54.79% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.